Reference |
117 Baker EJ, Ichiki AT, Day NE, Andrews RB, Bamberger EG, Lozzio CB. Simultaneous flow cytometric measurement of K-562 megakaryocytic differentiation and CD56+ large granular lymphocyte cytotoxicity J Immunol Methods 2001 253(1-2):37-44 PubMed ID: 11384667 |
98 Baker EJ, Ichiki AT, Hodge JW, Sugantharaj D, Bamberger EG, Lozzio CB. PMA-treated K-562 leukemia cells mediate a TH2-specific expansion of CD4+ T cells in vitro Leuk Res 2000 24(12):1049-57. PubMed ID: 11077119 DOI: 10.1016/s0145-2126(00)00082-5 |
97 Ichiki AT, Langenberg M, Baker EJ, Hodge JW, Bamberger EG, Gerard DA, Lozzio CB. Differential regulation of interleukin-1alpha and interleukin-1beta in K-562 cells J Interferon Cytokine Res 1998 18(12):1045-50 PubMed ID: 9877448 DOI: 10.1089/jir.1998.18.1045 |
101 Wust CJ, Hodge JW, Ichiki AT, Lozzio CB. Cell death in the human leukemia cell line, K-562, induced by antiserum and monoclonal antibodies Leuk Res 1991 15(6):497-506 PubMed ID: 1713636 DOI: 10.1016/0145-2126(91)90061-w |
103 Ichiki AT, Sugantharaj DG, Hudson CS, Gerard DA, Barnhill MA, Bamberger EG, Wust CJ, Fuhr JE, Lozzio CB. Lowered susceptibility of K-562 cells treated with gamma interferon in serum-free medium to natural killer cell-mediated cytolysis Nat Immun Cell Growth Regul 1988 7(5-6):297-304 PubMed ID: 3146698 |
106 Walter H, Krob EJ, Al-Romaihi FA, Johnson D, Lozzio CB. Detection of surface differences between closely related cell populations by partitioning. Cultured K-562 cell sublines Cell Biophys 1988 13(3):173-87 PubMed ID: 2465826 DOI: 10.1007/BF02918374 |
5042 Haruta Y, Seon BK. Distinct human leukemia-associated cell surface glycoprotein GP160 defined by monoclonal antibody SN6. Proc Natl Acad Sci U S A 1986 83(20):7898-902 PubMed ID: 3464004 DOI: 10.1073/pnas.83.20.7898 |
95 Ichiki AT, Bamberger EG, Wust CJ, Lozzio CB. Diversity of cell surface hematopoietic antigens on K-562 sublines identified with monoclonal antibodies Leuk Res 1986 10(5):565-74 PubMed ID: 2940421 DOI: 10.1016/0145-2126(86)90092-5 |
96 Ichiki AT, Wust CJ, Lozzio CB. Characterization of the Fc(IgG) receptor on the pluripotential leukaemia cell K-562 Clin Exp Immunol 1985 59(1):64-8 PubMed ID: 3971599 |
116 Rowley PT, Ohlsson-Wilhelm BM, Wisniewski L, Lozzio CB, Lozzio BB. K562 human leukemia cell passages differ in embryonic globin gene expression Leuk Res 1984 8(1):45-54 PubMed ID: 6199625 |
100 Lozzio BB, Machado EA, Mitchell J, Lozzio CB, Wust CJ, Golde DW. Proliferation of human malignant hematopoietic cells in immunodeficient mice: suppression by antibody to pluripotent K-562 leukemia cells involves direct cytolysis and effector cells Blood 1983 61(6):1045-53 PubMed ID: 6132631 |
94 Wust CJ, Green M, Lozzio CB, Lozzio BB. Antibody-dependent cytolysis of the human leukemia cell line K-562 in the absence of effector cells or complement Blood 1982 59(1):133-40 PubMed ID: 7053760 |
102 Ichiki AT, Lozzio BB, Wust CJ, Lozzio CB. Relationship between the Fc receptor for IgG and the specific associated antigen of the pluripotential leukaemia cell line, K-562 Clin Exp Immunol 1982 50(2):360-5 PubMed ID: 6185259 |
105 Machado EA, Gerard DA, Mitchell JR, Lozzio BB, Lozzio CB. Arrest and extravasation of neoplastic cells. An electron microscopy study of serial sections at sequential stages Virchows Arch A Pathol Anat Histol 1982 396(1):73-89 PubMed ID: 7123846 DOI: 10.1007/BF00428501 |
107 Lozzio CB, Lozzio BB, Wust CJ, Bamberger EG, Golde DW, Minowada J. Antibody lysis of human hematopoietic cells in the absence of complement and effector cells Exp Hematol 1982 10(8):698-707 PubMed ID: 6183138 |
115 Perez RL, Mitchell JR, Lozzio BB. Relevance of lipids to heterotransplantation of human malignancies Oncology 1982 39(3):179-84 PubMed ID: 7043353 DOI: 10.1159/000225632 |
87 Lozzio BB, Lozzio CB, Bamberger EG, Feliu AS. A multipotential leukemia cell line (K-562) of human origin Proc Soc Exp Biol Med 1981 166(4):546-50 PubMed ID: 7194480 DOI: 10.3181/00379727-166-41106 |
93 Fuhr JE, Bamberger EG, Lozzio CB, Lozzio BB. Induction of hemoglobin synthesis in original K 562 cell line Blood Cells 1981 7(2):389-99 PubMed ID: 6170369 |
108 Latif ZA, Lozzio BB, Wust CJ, Krauss S, Aggio MC, Lozzio CB. Evaluation of drug-antibody conjugates in the treatment of human myelosarcomas transplanted in nude mice Cancer 1980 45(6):1326-33 PubMed ID: 6928397 DOI: 10.1002/1097-0142(19800315)45:6<1326::aid-cncr2820450610>3.0.co;2-y |
113 Lair SV, Lozzio BB. Thymocyte reconstitution of athymic and athymic-asplenic mice: graft rejection and antibody synthesis Exp Cell Biol 1980 48(6):439-44 PubMed ID: 6967835 DOI: 10.1159/000163010 |
969 Rutherford TR, Clegg JB, Weatherall DJ. K562 human leukaemic cells synthesise embryonic haemoglobin in response to haemin. Nature 1979 280(5718):164-5 PubMed ID: 95354 DOI: 10.1038/280164a0 |
970 Andersson LC, Jokinen M, Gahmberg CG. Induction of erythroid differentiation in the human leukaemia cell line K562. Nature 1979 278(5702):364-5 PubMed ID: 570644 DOI: 10.1038/278364a0 |
89 Lozzio BB, Machado EA, Lair SV, Lozzio CB. Reproducible metastatic growth of K-562 human myelogenous leukemia cells in nude mice J Natl Cancer Inst 1979 63(2):295-9 PubMed ID: 287825 |
112 Lozzio CB, Lozzio BB, Wust CJ, Kim J. Correlation of leukemia-associated antigens and Ph1 chromosome in fibroblastlike cells derived from bone marrow Blood 1978 52(4):673-80 PubMed ID: 99197 |
114 Lozzio BB, Lozzio CB, Bamberger EG. Cytotoxicity of a factor from normal and abnormal human spleens for allogenic leukemia cells Am J Hematol 1978 4(1):57-65 PubMed ID: 655158 DOI: 10.1002/ajh.2830040108 |
99 Collins JL, Wust CJ, Lozzio BB, Lozzio CB. Characterization of an antigen from the myelogenous leukemia cell line K-562 J Natl Cancer Inst 1977 59(6):1667-74 PubMed ID: 72824 DOI: 10.1093/jnci/59.6.1667 |
109 Lozzio BB, Lozzio CB, Krauss S, Wust CJ, Girardi A. Leukemia-associated antigens detected by a nonhuman primate antiserum to a Ph1+ myeologenous leukemia cell line Blood 1977 50(1):115-24 PubMed ID: 68791 |
111 Lozzio BB, Machado EA, Lair SA, Lozzio CB. Suppression of human myelosarcoma growth in athymic mice by a primate antiserum Cancer Treat Rep 1977 61(9):1679-84 PubMed ID: 271518 |
88 Lozzio CB, Lozzio BB, Yang WK, Ichiki AT, Bamberger EG. Absence of thymus-derived lymphocyte markers in myelogenous leukemia (Ph1+) cell line K-562 Cancer Res 1976 36(12):4657-62 PubMed ID: 63324 |
104 Lozzio BB, Lozzi CB, Machado E. Human myelogenous (Ph+) leukemia cell line: transplantation into athymic mice J Natl Cancer Inst 1976 56(3):627-9 PubMed ID: 1062625 DOI: 10.1093/jnci/56.3.627 |
110 Lozzio BB, Machado EA, Lozzio CB, Lair S. Hereditary asplenic-athymic mice: transplantation of human myelogenous leukemic cells J Exp Med 1976 143(1):225-31 PubMed ID: 53268 DOI: 10.1084/jem.143.1.225 |